Cytotoxic Potential of Novel Quinoline Derivative: 11-(1,4-Bisaminopropylpiperazinyl)5-methyl-5H-indolo[2,3-b]quinoline against Different Cancer Cell Lines via Activation and Deactivation of the Expression of Some Proteins
Authors:
- Sara Fathy Abd ElrahmanSESara Fathy Abd Elrahman
- Abdullah A. S. AhmedAAAbdullah A. S. Ahmed
- Doaa Abd ElsatarDEDoaa Abd Elsatar
- Salma ElkadySESalma Elkady
- Amira ElgendyAEAmira Elgendy
- Fatma AlnakeebFAFatma Alnakeeb
- Elshaymaa I. ElmongyEEElshaymaa I. Elmongy
- Hanan A. HenidiHHHanan A. Henidi
- Saad M. El-GendySESaad M. El-Gendy
- Ibrahim El Tantawy El SayedISIbrahim El Tantawy El Sayed
- Ahmed A. El-GokhaAEAhmed A. El-Gokha
- Mabrouk Attia Abd EldaimMEMabrouk Attia Abd Eldaim
Open Access
- 20 September 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (18) , 14336
Abstract
The current study evaluated the cytotoxic activity of 11-(1,4-bisaminopropylpiperazinyl)5-methyl-5H-indolo[2,3-b]quinoline (BAPPN), a novel derivative of 5-methyl-5H-indolo[2,3-b]quinoline, against hepatocellular carcinoma (HepG2), colon carcinoma (HCT-116), breast (MCF-7), and lung (A549) cancer cell lines and the possible molecular mechanism through which it exerts its cytotoxic activity. BAPPN was synthesized and characterized with FT-IR and NMR spectroscopy. The binding affinity scores of BAPPN for caspase-3 PDB: 7JL7 was −7.836, with an RMSD of 1.483° A. In silico screening of ADME properties indicated that BAPPN showed promising oral bioavailability records in addition to their high gastrointestinal absorption and blood–brain barrier penetrability. BAPPN induced cytotoxicity, with IC50 values of 3.3, 23, 3.1, and 9.96 μg/mL against cancer cells HepG2, HCT-116, MCF-7, and A549, respectively. In addition, it induced cell injury and morphological changes in ultracellular structure, including cellular delayed activity, vanishing of membrane blebbing, microvilli, cytoplasmic condensation, and shrunken nucleus with more condensed chromatin autophagosomes. Furthermore, BAPPN significantly increased the protein expression of caspase-3 and tumor suppressor protein (P53). However, it significantly reduced the secretion of vascular endothelial growth factor (VEGF) protein into the medium and decreased the protein expression of proliferation cellular nuclear antigen (PCNA) and Ki67 in HepG2, HCT-116, MCF-7, and A549 cells. This study indicates that BAPPN has cytotoxic action against liver, colon, breast, and lung cancer cell lines via the up-regulation of apoptotic proteins, caspase-3 and P53, and the downregulation of proliferative proteins, VEGF, PCNA, and Ki67.Keywords
Funding Information
- Princess Nourah Bint Abdulrahman University (FRP-1444-13)
This publication has 54 references indexed in Scilit:
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryBreast Cancer Research and Treatment, 2013
- Role of p53 in Cell Death and Human CancersCancers, 2011
- Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cellsJournal of Biochemical and Molecular Toxicology, 2008
- PCNA, the Maestro of the Replication ForkCell, 2007
- Emerging roles of caspase-3 in apoptosisCell Death & Differentiation, 1999
- Regulation of CAK kinase activity by p53Oncogene, 1998
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantNature, 1994
- The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cellsLeukemia Research, 1992
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983